Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with Pluvicto plus standard of care (ARPI + ADT) in PSMAdditionConsistent ...

Over a month ago, I was on Instagram when I saw a video of a scientist who said, “They put the blood of people exercising on cancer cells, and the cancer cells died.”By now, we already know that ...

(NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...

Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of ...

The SPIRIT randomized trial provides level 1 data supporting short-term testosterone therapy to manage hypogonadal men with low grade, localized prostate cancer after radical prostatectomy.

In a randomized clinical trial, Mass General Brigham researchers found testosterone replacement therapy also improved quality of life for men who had undergone radical prostatectomy ...

The Israeli leader had surgery in 2024 for an enlarged prostate. More recently, follow-up care detected a tumor, his office disclosed on Friday. By David M. Halbfinger Reporting from Jerusalem Prime ...